Janis C. Kelly August 05, 2013 The first observational study of long-term antihypertensive use and breast cancer risk has found that calcium-channel blockers are associated with a more than 2-fold increased risk and that angiotensin-converting-enzyme (ACE) inhibitors are associated with a reduced risk. These findings come from a study published online August 5 in JAMA Internal Medicine. Women who had taken […]
Karimi Z, et al. Public Health Nutr. 2013 May 7:1-9. [Epub ahead of print] Abstract OBJECTIVE: Breast cancer is the most common type of cancer in women worldwide. Several studies have examined the role of single nutrients and food groups in breast cancer pathogenesis but fewer investigations have addressed the role of dietary patterns. Our […]
Published: Apr 12, 2013 By Cole Petrochko , Staff Writer, MedPage Today Action Points Pre-breast-cancer-diagnosis overall alcohol consumption was not associated with disease-specific survival, but there was a suggestion favoring moderate consumption. Alcohol consumption after diagnosis was not associated with disease-specific survival. Women who were moderate drinkers before being diagnosed with breast cancer appear to […]
Psychological after-effects of false-positive mammograms persisted for at least 3 years after women received the erroneous findings, investigators reported.
The type of dairy product that women with breast cancer consume could be an important lifestyle choice.
EVIDENCE-BASED RECOMMENDATIONS Jennifer Brunet, MA, Catherine M. Sabiston, PhD, Sarkis Meterissian, MD, MSc, FRCS(C), FACSDisclosures Am J Lifestyle Med. 2012;6(3):224-240. ABSTRACT AND INTRODUCTION Abstract The completion of primary treatment for breast cancer has been referred to as a “teachable moment” for health behavior change, suggesting that women are receptive to receiving physical activity counseling. However, […]
Jeffrey D Altenburg BMC Cancer201111:149 https://doi.org/10.1186/1471-2407-11-149 © Altenburg et al; licensee BioMed Central Ltd. 2011 Received: 26 January 2011 Accepted: 21 April 2011 Published: 21 April 2011 Abstract Background Breast cancer is a collection of diseases in which molecular phenotypes can act as both indicators and mediators of therapeutic strategy. Therefore, candidate therapeutics must be assessed in the context of multiple cell lines with known […]
Clarence H. Brown III, MD, Said M. Baidas, MD, Julio J. Hajdenberg, MD, Omar R. Kayaleh, MD, Gregory K. Pennock, MD, Nikita C. Shah, MD, Jennifer E. Tseng, MD Am J Lifestyle Med. 2009;3(5):337-348. ABSTRACT AND INTRODUCTION Abstract Despite evidence that cancer death rates in the United States are declining, the absolute number of new […]